ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,831 | -82.1% | 57,991 | -71.0% | 0.00% | – |
| Q1 2023 | $317,699 | -74.1% | 199,811 | +1.5% | 0.00% | – |
| Q4 2022 | $1,227,011 | +7.8% | 196,952 | +16.0% | 0.00% | – |
| Q3 2022 | $1,138,000 | +10.5% | 169,826 | +5.0% | 0.00% | – |
| Q2 2022 | $1,030,000 | +45.7% | 161,815 | +6.3% | 0.00% | – |
| Q1 2022 | $707,000 | +75.0% | 152,209 | +88.7% | 0.00% | – |
| Q4 2021 | $404,000 | -50.8% | 80,660 | +18.5% | 0.00% | – |
| Q3 2021 | $821,000 | -79.6% | 68,083 | -64.3% | 0.00% | -100.0% |
| Q2 2021 | $4,030,000 | -22.8% | 190,497 | +2.3% | 0.00% | -50.0% |
| Q1 2021 | $5,223,000 | +10.8% | 186,182 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $4,714,000 | -28.8% | 181,288 | +1.8% | 0.00% | -33.3% |
| Q3 2020 | $6,618,000 | -23.8% | 178,025 | +5.2% | 0.00% | -25.0% |
| Q2 2020 | $8,682,000 | +49.8% | 169,202 | -7.9% | 0.00% | +33.3% |
| Q1 2020 | $5,794,000 | -56.2% | 183,731 | -17.2% | 0.00% | -57.1% |
| Q4 2019 | $13,235,000 | +50.0% | 221,952 | -7.8% | 0.01% | +40.0% |
| Q3 2019 | $8,824,000 | +0.7% | 240,694 | +27.8% | 0.01% | 0.0% |
| Q2 2019 | $8,764,000 | +59.3% | 188,385 | +37.5% | 0.01% | +25.0% |
| Q1 2019 | $5,503,000 | -9.4% | 137,042 | +3.8% | 0.00% | -20.0% |
| Q4 2018 | $6,071,000 | +1.7% | 131,973 | -1.9% | 0.01% | +25.0% |
| Q3 2018 | $5,970,000 | +36.7% | 134,536 | +20.8% | 0.00% | +33.3% |
| Q2 2018 | $4,366,000 | -36.8% | 111,389 | +16.7% | 0.00% | -40.0% |
| Q1 2018 | $6,904,000 | +15.3% | 95,442 | +4.9% | 0.01% | 0.0% |
| Q4 2017 | $5,990,000 | +30.1% | 90,971 | -0.9% | 0.01% | +25.0% |
| Q3 2017 | $4,604,000 | +45.7% | 91,843 | +34.5% | 0.00% | +33.3% |
| Q2 2017 | $3,160,000 | +62.3% | 68,275 | +23.8% | 0.00% | +50.0% |
| Q1 2017 | $1,947,000 | +240.4% | 55,129 | +20.8% | 0.00% | +100.0% |
| Q4 2016 | $572,000 | +72.8% | 45,651 | +91.3% | 0.00% | – |
| Q3 2016 | $331,000 | -19.3% | 23,864 | -42.4% | 0.00% | -100.0% |
| Q2 2016 | $410,000 | -48.0% | 41,444 | -11.0% | 0.00% | 0.0% |
| Q1 2016 | $788,000 | -22.3% | 46,550 | +2.2% | 0.00% | 0.0% |
| Q4 2015 | $1,014,000 | -2.7% | 45,549 | +3.2% | 0.00% | -50.0% |
| Q3 2015 | $1,042,000 | -43.3% | 44,136 | +96.4% | 0.00% | -33.3% |
| Q2 2015 | $1,838,000 | +115.7% | 22,470 | +144.2% | 0.00% | +200.0% |
| Q1 2015 | $852,000 | +195.8% | 9,200 | +29.6% | 0.00% | – |
| Q4 2014 | $288,000 | – | 7,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |